Clinical Pharmacology in Drug Development|教育線上App不用買-HotApp4Game

Clinical Pharmacology in Drug Development (CPDD) is an official Journal of the American College of Clinical Pharmacology (ACCP). Established in 2012 in an online-only format, CPDD publishes high-quality clinical pharmacology studies in drug development which are primarily (but not exclusively) performed in early development phases in healthy subjects. CPDD is now available on your iPad. Fresh from the Newsstand, the CPDD app keeps you up to date with all the latest international news and peer-reviewed research.

Download the app today and enjoy a new browsing and reading experience, where you can:

• Download and read CPDD’s most recent issues

• Be notified when a new issue is available

• Save your favorite articles for quick and easy access offline

• Browse, search and bookmark articles from all available issues

• Share links to your favorite articles with colleagues and friends

CURRENT SUBSCRIBERS to Clinical Pharmacology in Drug Development can “pair” their device with their personal or institutional subscription to enjoy full access in this iPad edition.

SUBSCRIBE IN THE APP: Annual Subscriptions (4 issues) for the iPad-only edition are available for $249.99 (US) per year. Payment is charged to your iTunes account after confirmation of purchase. Clinical Pharmacology in Drug Development subscriptions automatically renew within 24 hours of the end of your subscription period for $249.99 (US) unless auto-renew is turned off at least 24 hours before the end of the subscription period. To turn off auto-renew, go to your iTunes account settings after purchase. Note that subscriptions cannot be cancelled during the term of the subscription, but you can still turn off auto-renew to prevent automatic renewal of your subscription. Note that any unused portion of a free trial period, if offered, will be forfeited when you purchases a subscription.

About the Journal

Clinical Pharmacology in Drug Development is an international, peer-reviewed, online publication focused on publishing high-quality clinical pharmacology studies in drug development which are primarily (but not exclusively) performed in early development phases in healthy subjects.

Acceptance of a manuscript in Clinical Pharmacology in Drug Development will be determined by scientific rigor and technical soundness rather than perceived importance of the presented results. Thus, negative study results are explicitly not an obstacle for positive acceptance decisions.